Results of VERTIS SU extension study: safety and efficacy of ertugliflozin treatment over 104 weeks compared to glimepiride in patients with type 2 diabetes mellitus inadequately controlled on Metformin - Hollander, P; Hill, J; Johnson, J (Curr Med Res Opin, 2019)